After the genome, AstraZeneca taps 'secretome' for novel drugs

LONDON AstraZeneca is diving into the world of proteins secreted by cells – collectively known as the secretome – in the hunt for new drugs and better “cell factories” for making biotech medicines.

The so-called secretome accounts for around one third of human proteins and the idea of mapping them all follows the decoding of the human genome in 2000, since when there has been a surge in scientific buzzwords ending in “ome”.

The secretome is…

See original

You may also like...